id	keyword
dpc-3740	patients
dpc-3740	cscc
dpc-3740	pmid
dpc-3740	cell
dpc-3740	doi
dpc-3740	carcinoma
dpc-3740	treatment
dpc-3740	cemiplimab
dpc-3740	study
dpc-3740	cancer
dpc-3740	response
dpc-3740	risk